Navigation Links
Targeted drug therapy prevents exercise-induced arrhythmias
Date:3/29/2009

A 12-year-old Dutch boy bedridden for three years because of an inherited cardiac arrhythmia syndrome can now join his friends on the soccer field thanks to a discovery made by Vanderbilt University Medical Center researchers.

The investigators, led by Bjrn Knollmann, M.D., Ph.D., report this week in Nature Medicine that the clinically available drug flecainide prevents potentially lethal arrhythmias in patients with a specific type of exercise or stress-induced arrhythmia disorder called CPVT.

"It's potentially a breakthrough in the treatment of this rare syndrome," said Knollmann, associate professor of Medicine and Pharmacology.

Patients with CPVT experience abnormally rapid heart rates (tachycardia), usually during exercise or stress, and are at risk for fainting and cardiac arrest. The syndrome kills up to 50 percent of untreated patients, and it may account for some unexplained sudden cardiac deaths in young athletes.

Current treatment has been limited to two medications beta blockers, often used at very high doses, and calcium channel blockers to control the arrhythmias.

Implantable cardioverter defibrillators (ICDs) are placed in patients at high risk for sudden death, but ongoing arrhythmias can result in frequent stressful shocks.

The Dutch patient, for example, experienced ventricular tachycardia and ICD shocks whenever he got out of bed, Knollmann said.

Defibrillator therapy also can be problematic for pediatric patients (CPVT is usually diagnosed in children), who require multiple surgical revisions of their systems.

"For this particular disease, the ICD is a suboptimal treatment," he said. "It's extremely desirable to have a drug treatment that reduces or prevents the ventricular tachycardias, and therefore prevents the ICD shocks."

Knollmann and his team have been studying the molecular defects that trigger arrhythmias. They knew that mutations in two genes that enco
'/>"/>

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
2. Microarray sequence capture speeds large-scale resequencing of targeted genomic regions
3. Researchers combat slowing yields with targeted fertilizer applications
4. Fishing throws targeted species off balance, Scripps study shows
5. New technique allows targeted inactivation of genes in research model
6. Newly identified role for power plants in human cells could lead to targeted therapies
7. Consortium develops new method enabling routine targeted gene modification
8. On the trail of a targeted therapy for blood cancers
9. Cellular discovery may lead to targeted treatment for rare form of anemia
10. Molecular fingerprints point the way to earlier cancer diagnosis and more targeted treatment
11. A new radiation therapy treatment developed for head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 18, 2014   EyeLock Inc. , a ... MorphoTrust USA (Safran), a leading U.S. ... a strategic partnership to offer comprehensive biometric identity ... (MVA), airport screening and financial services markets. ... serves consumers through a nationwide network of 1,100 ...
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
(Date:11/6/2014)... when that predator runs so fast that it essentially blinds ... the fastest creature on Earth. Some of these half-inch-long beetles ... miles per hour). The fastest human can do about five ... beetle, a person would have to hit 480 miles per ... peak speeds, everything becomes a blur. They can,t gather enough ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3The tiger beetle: Too fast to see 2
... Scientists will soon be exploring matter at temperatures and ... microseconds using powerful pulsed lasers. Matter in such states ... kilometres beneath the surface, and also in elusive "warm ... X-ray beamline ID24 at the European Synchrotron Radiation Facility ...
... , SAN FRANCISCO (Nov. 9, 2011; 12:50 p.m.) ... an investigational intravenous antiplatelet, showed patients can be "bridged" ... oral antiplatelet drugs until they undergo cardiac surgery. ... inhibition known to be associated with a low risk ...
... use of genetic analysis to help save a boy imperiled ... change in two localities, and on the secret lives of ... AAAS Kavli Science Journalism Awards. The awards, administered by ... for distinguished reporting for a general audience. The Kavli Foundation ...
Cached Biology News:Exploring the last white spot on Earth 2Exploring the last white spot on Earth 3Scripps Health/the Medicines Company announce late breaking BRIDGE trial results presented at TCT 2Winners named for the 2011 AAAS Kavli Science Journalism Awards 2Winners named for the 2011 AAAS Kavli Science Journalism Awards 3Winners named for the 2011 AAAS Kavli Science Journalism Awards 4Winners named for the 2011 AAAS Kavli Science Journalism Awards 5Winners named for the 2011 AAAS Kavli Science Journalism Awards 6Winners named for the 2011 AAAS Kavli Science Journalism Awards 7Winners named for the 2011 AAAS Kavli Science Journalism Awards 8Winners named for the 2011 AAAS Kavli Science Journalism Awards 9
(Date:11/22/2014)... IL (PRWEB) November 21, 2014 On ... competitors at the 2014 Emerging Medical Technologies Summit in ... Innovator Awards. Widely regarded among Silicon Valley investors ... medical device innovation, the win also positions Briteseed ... MedTech Innovator competition in 2015 and compete with other ...
(Date:11/22/2014)... November 21, 2014   ... Chief Commercial Officer zu KLOX    ... und Chief Financial Officer bestellt    ... Vermarktung seines jüngst zugelassenen Behandlungssystems zur Wundheilung zu beginnen ... das "Unternehmen") ist sehr erfreut, die folgenden personellen Veränderungen ...
(Date:11/21/2014)... Diego, CA (PRWEB) November 20, 2014 ... extended their Sartorius Entris Balance promotion . The ... customers seeking a durable, high accuracy, and easy-to-maintain balance ... made in Germany. It was designed to help customer’s ... affordable and a balance that is very durable. Sartorius ...
(Date:11/21/2014)... NY (PRWEB) November 20, 2014 The ... now available as an open access journal featuring the ... infrared fluorescent proteins to preserve photoresponsiveness in the retina ... Two-color fluorescent in situ hybridization using chromogenic substrates in ... for DNA, RNA, and protein electrophoresis , ...
Breaking Biology Technology:Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 3KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5Pipette.com Announces an Extension on the Sartorius Entris Balance Promotion to the End of 2014 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3
... Presented, CHARLES TOWN, W.Va., Nov. 23 ... a provider of treatment for,diabetic peripheral neuropathy ... concluded analysis of the recent volatility of ... Board of Directors., (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ...
... AMDL, Inc. (Amex: ADL,- News), headquartered ... and Jilin, China, through its wholly owned ... biopharma company that,engages in the development, manufacture ... The Company announced today that,the recent presentation ...
... University of Pittsburgh have created the best method so ... wide, a significant step in science,s increasing attempts to ... single molecule scale and provide smaller, faster, and more ... 26 in the Journal of the American Chemical Society ...
Cached Biology Technology:ReBuilder Medical Technologies, Inc.'s Recent Stock Price Volatility Explained 2AMDL Presentation of China Success Story from Rodman & Renshaw Annual Healthcare Conference Available at WallStreetReporter.com 2
... Mediated Purification with an Affinity Chitin-binding Tag) ... protein splicing elements (termed inteins) to purify ... (1-4) (Figures 1 and 2). This system ... by its ability to separate a recombinant ...
... Kit provides the reagents to efficiently ... skeletal myotubes. By efficiently promoting myogenic ... tool in studies examining myogenesis, transcription ... for muscle cell replacement therapy. By ...
The Saturn 2200 answers your GC/MS questions with the CP-3800 GC and the 2000 Series Ion Trap MS! These components create a platform for the worlds most versatile GC and flexible MS. Both deliver une...
... of E-PAGE Gels easier and more efficient ... and several types of pre-cut pre-assembled membrane/filter ... x 13.5 cm E-PAGE Gels*. The available ... for western transfer of proteins (Figure 1 ...
Biology Products: